China approves brain-computer interface devices as startups challenge Neuralink

Chinese regulators have approved multiple brain-computer interface products this year, as domestic startups aim to surpass Elon Musk's Neuralink in treating conditions like paraplegia, Alzheimer's, and depression. Beijing is offering policy support to lead globally in this technology. Approved products include a cognitive assessment cap by Tiankai Suishi, approved August 19, and a micro-electrode driver by StairMed Technology, backed by Tencent and Alibaba, approved in June. Neuracle Medical won approval in March for an implantable device aiding hand movement in spinal cord injuries. Local governments are boosting support, with Zhejiang encouraging public listings and Shenzhen aiding overseas expansion. China's ageing population has driven neurological disorder cases from 329 million in 1990 to 468 million by 2021, with the BCI market projected to reach 6.14 billion yuan by 2028.